当前位置:首页 - 行情中心 - 亚宝药业(600351) - 财务分析 - 现金流量表

亚宝药业

(600351)

  

流通市值:46.05亿  总市值:46.05亿
流通股本:7.70亿   总股本:7.70亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,070,956,312.891,397,695,211.74672,430,780.122,438,370,247.25
收到的税费返还1,907,684.531,067,572.04586,092.0512,563,662.32
收到其他与经营活动有关的现金72,623,918.344,056,152.626,352,563.6983,632,086.92
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,145,487,915.721,442,818,936.38699,369,435.862,534,565,996.49
购买商品、接受劳务支付的现金566,847,616.92363,399,936.84201,989,443.49609,355,322.08
支付给职工以及为职工支付的现金375,730,693.97262,165,395.22132,623,707.48492,909,210.92
支付的各项税费217,756,940.93156,572,896.4188,524,233.34232,147,934.23
支付其他与经营活动有关的现金650,617,519.01405,944,598.51181,806,871.28739,690,946.44
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,810,952,770.831,188,082,826.98604,944,255.592,074,103,413.67
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额334,535,144.89254,736,109.494,425,180.27460,462,582.82
二、投资活动产生的现金流量:
收回投资收到的现金21,249,820.4615,520,010.593,829,524.53124,666,994
取得投资收益收到的现金84,010.1280,248.9149,9925,121,598.16
处置固定资产、无形资产和其他长期资产收回的现金净额520,345224,390.9697,0001,253,678.61
投资活动现金流入的平衡项目0000
投资活动现金流入小计21,854,175.5815,824,650.463,976,516.53131,042,270.77
购建固定资产、无形资产和其他长期资产支付的现金80,059,949.1149,312,265.121,318,354.5162,231,753.83
投资支付的现金68,946,310.6221,504,978.6411,666,765.84165,541,049.45
投资活动现金流出的平衡项目0000
投资活动现金流出小计149,006,259.7370,817,243.7432,985,120.35227,772,803.28
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-127,152,084.15-54,992,593.28-29,008,603.82-96,730,532.51
三、筹资活动产生的现金流量:
取得借款收到的现金348,600,000129,903,555.56139,903,555.56619,526,805.56
筹资活动现金流入平衡项目0000
筹资活动现金流入小计348,600,000129,903,555.56139,903,555.56619,526,805.56
偿还债务支付的现金539,800,000220,000,000130,000,000712,600,000
分配股利、利润或偿付利息支付的现金49,137,661.2146,565,093.173,831,005.5481,609,405.65
支付其他与筹资活动有关的现金104,039,213.2773,324,564.832,265,277.523,953,704.73
筹资活动现金流出平衡项目0000
筹资活动现金流出小计692,976,874.48339,889,658136,096,283.06798,163,110.38
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-344,376,874.48-209,986,102.443,807,272.5-178,636,304.82
四、汇率变动对现金及现金等价物的影响-11,614.714,374.48-69,425.98222,385.99
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-137,005,428.44-10,228,211.8469,154,422.97185,318,131.48
加:期初现金及现金等价物余额642,021,376.52642,021,376.52642,021,376.52456,703,245.04
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额505,015,948.08631,793,164.68711,175,799.49642,021,376.52
补充资料:
净利润-166,592,333.19-104,604,305.82
资产减值准备-1,364,192.53-68,059,389.92
固定资产和投资性房地产折旧-73,083,204.2-144,569,261.55
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-73,083,204.2-144,569,261.55
无形资产摊销-5,057,476.17-15,401,284.88
长期待摊费用摊销-162,658.1-556,793.16
处置固定资产、无形资产和其他长期资产的损失--946,183.39--116,093.98
固定资产报废损失-155,329.94-836,074.87
公允价值变动损失-107,043.65-3,541,333.5
财务费用-8,333,940.25-19,028,668.03
投资损失-1,542,194.25-631,224.32
递延所得税--3,934,861.61--7,529,527.96
其中:递延所得税资产减少--3,594,799.23--4,461,496.68
递延所得税负债增加--340,062.38--3,068,031.28
存货的减少-56,463,447.46-61,026,538.1
经营性应收项目的减少-10,556,933.62--6,953,885.62
经营性应付项目的增加--69,856,758.53-44,909,924.98
融资租入固定资产---330,301.86
现金的期末余额-631,793,164.68-642,021,376.52
减:现金的期初余额-642,021,376.52-456,703,245.04
公告日期2023-10-282023-08-232023-04-262023-04-26
审计意见(境内)标准无保留意见
TOP↑